相关实验视频
Updated: Jul 20, 2026
08:29
Establishment and Culture of Patient-Derived Breast Organoids
Published on: February 17, 2023
4.4K
患者衍生器官在药物开发中的机会
Antonia Büning1, Elena Reckzeh1
1Transdisciplinary Research Area 'Life and Health', LIMES Institute, University of Bonn, Bonn, Germany.
British journal of pharmacology
|February 20, 2025
概括
患者衍生器官 (PDO) 为药物开发提供了一个比传统方法更准确的模型. 这些先进的3D模型通过更好地反映人类生理学来改善药物发现和个性化医疗.
科学领域:
- 生物医学研究的研究.
- 药物的发现和开发.
- 再生医学是一种再生医学.
背景情况:
- 传统的药物开发模型,如二维细胞系和动物模型,在捕捉人类生理复杂性和异质性方面存在局限性.
- 由于物种差异和缺乏细胞多样性,现有的模型往往无法准确地代表人类疾病或预测药物反应.
研究的目的:
- 审查在药物开发中利用患者衍生有机物 (PDO) 的示范方法.
- 突出成人干细胞 (ASC) 衍生器官的发展机会和潜力.
- 展示PDO如何能够促进药物开发,从基础研究到临床应用,包括个性化医疗.
主要方法:
- 审查当前的文献和实例案例研究关于患者衍生器官 (PDO) 的应用.
- 专注于成年干细胞 (ASC) 的器官发育,以创建生理相关的3D模型.
- 在相关性和准确性方面,PDO与传统的二维细胞系和动物模型的比较.
主要成果:
- 与传统的二维细胞系相比,有机体提供了更具生理相关性的三维 (3D) 模型.
- 患者衍生器官 (PDO) 非常类似于健康和病态的人类组织的分子状态.
- 成人干细胞 (ASC) 衍生有机体显示出改善药物疗效和安全性评估的巨大潜力.
结论:
- 患者衍生器官 (PDO) 代表了药物开发的重大进步,提供了更好的生理相关性.
- 使用PDO,特别是来自成年干细胞 (ASC) 的产物,可以提高药物查和临床前测试的准确性.
- 器官技术在推进个性化医疗方面具有很大的前景,因为它可以预测患者特异性的药物反应.
相关概念视频
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...